Prof. Dr. Şener Cihan

• Lung Neoplasms 9 publications
  Source: OpenAlex / PubMed MeSHView publications
• Carcinoma, Non-Small-Cell Lung 7 publications
• Colorectal Neoplasms 7 publications
• Breast Neoplasms 5 publications
• Liver Neoplasms 4 publications
• Stomach Neoplasms 4 publications
• Testicular Neoplasms 4 publications
• Rectal Neoplasms 4 publications
• Neoplasms 3 publications
• Adenocarcinoma 2 publications
• Bone Neoplasms 2 publications
• Gastrointestinal Neoplasms 2 publications
• Neoplasms, Germ Cell and Embryonal 2 publications

Medical areas of interest stated by the doctor on the institution profile. Source: medicalpark.com.tr.

Experience

• 19931994 Pratisyen Doktor Senirkent Devlet Hastanesi Senirkent, Ispartamedicalpark.com.tr
• 19941999 Araştırma Görev Ondokuz Mayıs Üniversitesi Tıp Fakültesi İç hastalıkları ABD, Samsunmedicalpark.com.tr
• 20002006 Uzman Doktor Diyarbakır SSK hastanesi, Diyarbakırmedicalpark.com.tr
• 20062008 Uzman Doktor Diyarbakır Devlet Hastanesi, Diyarbakırmedicalpark.com.tr
• 20082011 Dr. Yan Dal Asistanı Ankara Numune Eğitim ve Araştırma Hastanesimedicalpark.com.tr
• 20112013 Uzman Doktor Diyarbakır Eğitim ve Araştırma Hastanesi, Tıbbi Onkolojimedicalpark.com.tr
• 20132016 Uzman Doktor Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbi Onkoloji Kliniğimedicalpark.com.tr
• Experience2016 Eğitim Sorumlusu Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbi Onkoloji Kliniği, Doç.Dr.medicalpark.com.tr

Education

• 19871993 Lisans Tıp Fakültesi, Uludağ Üniversitesi Tıp Fakültesimedicalpark.com.tr
• 19941999 Lisans İç Hastalıkları Ondokuz Mayıs Üniversitesi Tıp Fakültesimedicalpark.com.tr
• 20082011 Doktora Tıbbi Onkoloji Ankara Numune Eğitim ve Araştırma Hastanesimedicalpark.com.tr
• Education2016 Doç.Dr / Prof. Dr. Tıbbi Onkoloji Okmeydanı Eğitim ve Araştırma Hastanesimedicalpark.com.tr

• SpecialtyMedical Oncologymedicalpark.com.trFrom source
• Department name at the sourceMedikal Onkoloji (Tıbbi Onkoloji)medicalpark.com.trFrom source
• Institutionİstinye Üniversitesi Medical Park Gaziosmanpaşamedicalpark.com.trFrom source
• Area of workLung NeoplasmsExtracted from 9 publications · Model version —From source
• Publications100 publicationsOpenAlex, ORCIDFrom source
• ORCID0000-0002-3960-4982ORCIDFrom source
• Last synchronised4 November 2026 20:30https://www.medicalpark.com.tr/hekimler/sener-cihanmedicalpark.com.tr

1. Factors influencing hospital length of stay in febrile neutropenia: A retrospective cohort study of Turkish patients with solid tumors

   Medicine, 2025

   DOI 10.1097/md.0000000000043105 PMID 40629594 5 citations (OpenAlex) Open-access full textSource: OpenAlex

2. Perioperative 5-fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) regimen in gastric cancer: Pathological regression grade and its relationship to clinical outcome

   Indian Journal of Cancer, 2024

   DOI 10.4103/ijc.ijc_1283_20 PMID 39960699 2 citations (Europe PMC) Open-access full textSource: OpenAlex

3. Patient and treatment characteristics in HR+/HER2-metastatic breast cancer in a real-life setting

   Cancer Research, 2023

   DOI 10.1158/1538-7445.sabcs22-p4-03-40 Source: ORCID

4. First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal carcinoma

   Bosnian Journal of Basic Medical Sciences, 2022

   DOI 10.17305/bjbms.2021.7069 PMID 35460397 4 citations (Europe PMC) Open-access full textSource: OpenAlex

5. Efficacy of Imatinib on Advanced and Refractory Desmoid Tumors: A Retrospective Study

   Journal of Oncological Sciences, 2022

   DOI 10.37047/jos.2021-87391 Open-access full textSource: OpenAlex

6. Evaluation of acute and chronic nephrotoxicity in patients received cisplatin-based chemotherapy: has anything changed over time?

   International Urology and Nephrology, 2022

   DOI 10.1007/s11255-021-02975-8 PMID 34390437 3 citations (Europe PMC) Source: ORCID

7. The evaluation of urinary calprotectin levels for prediction of acute cisplatin-induced nephrotoxicity

   Medicine, 2022

   DOI 10.1097/md.0000000000029814 PMID 35777022 1 citation (Europe PMC) Open-access full textSource: ORCID

8. Clinical and Pathological Characteristics of Patients with High-Risk Breast Cancer Based on BRCA Mutation Profiles: A Retrospective Study

   European Journal of Breast Health, 2021

   DOI 10.4274/ejbh.galenos.2020.6346 PMID 33870111 11 citations (Europe PMC) Open-access full textSource: OpenAlex

9. The Prognostic Value of Postoperative Lymph Node Ratio in Gastric Adenocarcinoma Patients Treated With Neoadjuvant Chemotherapy

   Cureus, 2021

   DOI 10.7759/cureus.14639 PMID 34046274 5 citations (Europe PMC) Open-access full textSource: OpenAlex

10. The Predictive Value of Baseline Volumetric PET/CT Parameters on Treatment Response and Prognosis in Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy

    Journal of Gastrointestinal Cancer, 2021

    DOI 10.1007/s12029-021-00608-y PMID 33651265 11 citations (Europe PMC) Open-access full textSource: OpenAlex